Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer? - Wikidata - wikimedia - TriplyDB

Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

http://www.wikidata.org/entity/Q51727954

about

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.

P2860

Q48047542-545FDB5B-937D-4B27-B19D-B0760686C39E

P2860

Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

http://www.wikidata.org/entity/Q51727954

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

@en

type

label

Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

@en

prefLabel

Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

@en

P1433

Q51727954-2783A02E-8390-43BC-B025-5897518F602C

P1476

Q51727954-C4F86CDF-AF5F-45DC-BC3C-057ECECAF85A

P2093

Q51727954-886B9D9A-D746-4984-A581-11499E648833

Q51727954-EBD27B3F-9F7D-442F-ABA9-FAEF2E79EB6D

P2860

Q51727954-09F651CC-3FF7-4952-9706-86917AEEF237

Q51727954-1A6D8740-BA54-4268-A4E3-8996C3EE2151

Q51727954-34100B35-DA0C-4517-A968-712894C2F8EF

Q51727954-39F855B8-8F1F-4A71-BCDC-8E61CEC6D5F3

Q51727954-5A1961CD-4FDB-43A0-9FB8-C73617626CEF

Q51727954-8F2AEE9B-6052-4553-A157-ECC6524D1A48

Q51727954-8F9CE13F-625C-45AC-996F-153691D14644

Q51727954-A8E45561-3751-4773-88C8-08B0C0791542

Q51727954-AAF21767-DB91-4A83-B8F8-9AEC7991E2D6

Q51727954-B133B444-44B4-4830-A433-7BDB07405D70

P2888

Q51727954-789871C2-6FAD-42F2-AB1D-5109D5F3F69E

P304

Q51727954-FC9485D7-7BB7-45A2-8EC3-023152DBB2D9

P31

Q51727954-6198B57E-16C4-4069-B77F-320763AF825C

Q51727954-b7555e29-a2c2-41be-955e-87152a060eba

P356

Q51727954-DEF41E3D-0986-4C4A-8CE8-9A634714BA9E

P433

Q51727954-E1F3EB4F-6993-4DCF-9B32-78A6EA953015

P478

Q51727954-B672B44B-A13D-4D9D-B1C6-B9B60BE9FBC4

P577

Q51727954-47289D48-38FF-4AFA-9642-4B6E56C0BDF8

P698

Q51727954-9A3E38D4-5F6D-4CDA-B77C-2A7327D84FA5

P356

S00259-016-3430-5

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

@en

P2093

David Groheux

http://www.w3.org/2001/XMLSchema#string

Elif Hindié

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

[18F]-fluorodeoxyglucose positron emission tomography can contribute to discriminate patients with poor prognosis in hormone receptor-positive breast cancer

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.

Performance of FDG PET/CT in the clinical management of breast cancer.

PET imaging of oestrogen receptors in patients with breast cancer.

¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.

Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.

P2888

s00259-016-3430-5

P304

1571-1573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-016-3430-5

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27245758

http://www.w3.org/2001/XMLSchema#string